Grade 4 unclassified renal cell carcinoma with sarcomatoid component expressing S-100 protein. A case report with peculiar diagnostic and therapeutic implications
- 2 November 2014
- journal article
- case report
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 15 (11) , 1439-1443
Abstract
Grade 4 unclassified renal cell carcinoma, with sarcomatoid component (URCCSC) is a rare high grade tumour presumptively derived from all histological subtypes of renal cell carcinoma (RCC). Even though rare, URCCSC generates a great deal of interest, as it is a particularly aggressive variant of RCC, that is poorly responsive to chemo-immunotherapy. Whether it originates from a separate sarcomatoid cell clone within the tumour or from true cell dedifferentiation from RCC has yet to be established. The diagnosis of URCCSC is usually based on morphological and immunohistochemical characteristics of the neoplastic cells which show transitional epithelial/mesenchymal features. In fact, the frequent loss of epithelial markers and gain of mesenchymal phenotypes, can result in difficulties in interpreting diagnostic data. Consequently assigning the optimal therapeutic treatments can be hindered due to this biological “complexity”. Here we present the clinicopathological records of a 51 year-old patient ...Keywords
This publication has 17 references indexed in Scilit:
- The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic ParametersAmerican Journal of Surgical Pathology, 2013
- Sarcomatoid renal cell carcinoma is an example of epithelial–mesenchymal transitionJournal of Clinical Pathology, 2011
- Worldwide Variations in Colorectal CancerCA: A Cancer Journal for Clinicians, 2009
- Pseudosarcomatous fibroblastic/myofibroblastic proliferation in perinephric adipose tissue adjacent to renal cell carcinoma: a lesion mimicking well-differentiated liposarcomaLaboratory Investigation, 2009
- Cytology of a sarcomatoid renal cell carcinoma with unusual coexpression of S‐100 protein: A case report, review of the literature and cytologic–histologic correlationDiagnostic Cytopathology, 2008
- Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature reviewCancer Treatment Reviews, 2008
- The role of epithelial-mesenchymal transition in cancer pathologyPathology, 2007
- Doxorubicin and Ifosfamide in Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: A Phase II Study of the Genitourinary Group of the French Federation of Cancer CentersJournal of Urology, 2002
- Sarcomatoid Differentiation in Renal Cell CarcinomaAmerican Journal of Surgical Pathology, 2001
- Phase II trial of combination chemotherapy with dacarbazine, cyclophosphamide, cisplatin, doxorubicin, and vindesine (DECAV) in advanced renal cell cancerUrology, 1989